nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 05, v.45 520-526
内热针治疗纤维肌痛综合征的临床研究
基金项目(Foundation): 兰州市卫生健康行业医药卫生科研项目(编号:A2024024)
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2026.05.012
投稿时间: 2025-07-06
投稿日期(年): 2025
修回时间: 2025-10-14
终审时间: 2025-10-08
终审日期(年): 2025
审稿周期(年): 1
发布时间: 2026-05-05
出版时间: 2026-05-05
移动端阅读
摘要:

目的:观察运用内热针治疗纤维肌痛综合征(FMS)的临床疗效。方法:选择FMS患者60例作为研究对象,按照随机数字表法分为观察组和对照组各30例。对照组采用普通针刺治疗,观察组给予内热针治疗,观察两组患者治疗前、治疗后、治疗后3个月视觉模拟评分法(VAS)、修订版FMS影响问卷调查表(FIQR)、汉密尔顿抑郁量表(HAMD)评分变化情况;对各时间点所采集的数据进行统计分析处理,观察治疗前后组间、组内变化,进行临床疗效比较。结果:(1)研究过程中,观察组失访2例,剔除1例,对照组剔除1例,脱落1例。最终观察组27例、对照组28例纳入疗效统计。(2)观察组总有效率为88.9%,对照组为71.4%,观察组临床疗效优于对照组,差异有统计学意义(P<0.05)。(3)全部疗程结束后,两组患者的VAS评分均较治疗前下降(P<0.05),但组间比较差异无统计学意义(P=0.683)。(4)治疗后两组患者HAMD评分均较治疗前降低(P<0.05),观察组HAMD评分低于对照组(P<0.05)。(5)治疗后两组患者FIQR评分均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05)。(6)3个月后随访数据显示,两组患者VAS评分、HAMD评分、FIQR评分均较治疗前降低(P<0.05),且观察组以上三项指标的维持效果均优于对照组(P<0.05)。(7)治疗结束3个月后,观察组复发率为11.11%,低于对照组(28.57%),差异有统计学意义(P<0.05)。结论:内热针应用于FMS治疗,可有效减轻患者疼痛症状,改善躯体功能障碍、情绪障碍、睡眠障碍,临床疗效显著,预后更佳。

Abstract:

Objective:To observe the clinical efficacy of internal heat acupuncture in the treatment of fibromyalgia syndrome(FMS). Methods:Sixty patients with FMS were selected as the study subjects and randomly divided into an observation group and a control group using the random number table method,30 cases in each group. The control group received conventional acupuncture treatment,while the observation group was treated with internal heat acupuncture. Changes in the visual analogue scale(VAS),the revised fibromyalgia impact questionnaire(FIQR),and the Hamilton depression rating scale(HAMD) scores were observed in both groups before treatment,after treatment,and 3 months after treatment. Statistical analyses were performed on the data collected at each time point to evaluate within-group and between-group changes and to compare clinical efficacy. Results:(1)During the study,2 cases in the observation group were lost to follow-up and 1 case was excluded;in the control group,1 case was excluded and 1 case dropped out. Ultimately,27 patients in the observation group and 28 in the control group were included in the efficacy analysis.(2)The total effective rate was 88.9% in the observation group and 71.4% in the control group. The clinical efficacy of the observation group was superior to that of the control group,and the difference was statistically significant(P<0.05).(3)After completion of the full treatment course,the VAS scores in both groups were significantly lower than those before treatment(P<0.05),but there was no statistically significant difference between the two groups(P=0.683).(4)After treatment,the HAMD scores in both groups were significantly reduced compared with those before treatment(P<0.05),and these in the observation group were lower than those in the control group(P<0.05).(5)After treatment,the FIQR scores in both groups were significantly lower than those before treatment(P<0.05),and these in the observation group were lower than those in the control group(P<0.05).(6)Follow-up data at 3 months showed that the VAS,HAMD,and FIQR scores in both groups remained significantly lower than those before treatment(P<0.05),and the observation group demonstrated better maintenance effects than the control group in all three indicators(P<0.05).(7)Three months after the end of treatment,it showed that the recurrence rate in the observation group(11.11%) was lower than that in the control group(28.57%),with a statistically significant difference(P<0.05). Conclusions:Internal heat acupuncture can effectively alleviate pain symptoms in patients with FMS and improve physical dysfunction,emotional disturbance,and sleep disturbance. It shows significant clinical efficacy and yields a better prognosis.

参考文献

[1]SARZI-PUTTINI P,GIORGI V,MAROTTO D,et al. Fibromyalgia:an update on clinical characteristics,aetiopathogenesis and treatment[J]. Nat Rev Rheumatol,2020,16(11):645-660.

[2]HAUSER W,ABLIN J,FITZCHARLES M A,et al. Fibromyalgia[J]. Nat Rev Dis Primers,2015,1:15022.

[3]WEST S. Rheumatology secrets[M]. 3rd ed. Philadelphia:Mosby,2014:467-469.

[4]ALLES S R A,SMITH P A. Etiology and pharmacology of neuropathic pain[J]. Pharmacol Rev,2018,70(2):315-347.

[5]付勇刚,宋世琴.清络宣痹汤联合普瑞巴林对纤维肌痛综合征患者外周血MCP-1、MIP-1β和G-CSF水平的影响[J].现代中西医结合杂志,2017,26(22):2484-2486,2497.

[6]魏嘉辛,王刚,厚双龙.纤维肌痛综合征中枢性疼痛机制及物理治疗的研究进展[J].医学理论与实践,2024,37(13):2189-2191,2195.

[7]刘妍辰,高明利.纤维肌痛综合征的中医外治法研究进展[J].风湿病与关节炎,2018,7(1):77-80.

[8]向伟,李信明,陈智,等.内热针疗法的传承与创新[J].中国中医药现代远程教育,2024,22(23):80-83.

[9]WOLFE F,CLAUW D J,FITZCHARLES M A,et al.2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria[J]. Semin Arthritis Rheum,2016,46(3):319-329.

[10]中华中医药学会风湿病分会,海峡两岸医药卫生交流协会风湿免疫病学专业委员会纤维肌痛综合征中西医研究学组,首都中西医结合风湿免疫病研究所.中国纤维肌痛综合征诊疗指南[J].中华内科杂志,2023,62(2):129-146.

[11]WHIPPLE M O,MCALLISTER S J,OH T H,et al.Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria[J]. Clin Transl Sci,2013,6(5):398-399.

[12]张哲浩.纤维肌痛综合征临床药物治疗研究进展[J].临床药物治疗杂志,2018,16(5):26-30.

[13]刘佳利,路雪芹,鲍亚丽,等.纤维肌痛综合征非药物治疗和护理研究进展[J].河南大学学报(医学版),2023,42(3):167-171.

[14]杜芸,徐江喜,王丹,等.基于“阳气者,精则养神,柔则养筋”理论论治纤维肌痛综合征思路[J].中华中医药杂志,2022,37(6):3312-3315.

[15]姜传捷,赵镇涛,殷之珺,等.从足太阳膀胱经论治纤维肌痛综合征理论探析[J].按摩与康复医学,2023,14(8):55-58.

[16]原林,白宇,王军,等.经络的解剖学发现与筋膜学理论[C]//中国针灸学会实验针灸分会,中国针灸学会经络分会,《上海针灸杂志》编辑部.第十五届针灸对机体功能的调节机制及针灸临床独特经验研讨会暨第十一届针灸经络学术研讨会论文集.上海,2010:77-80.

[17]王军.人体四肢经穴筋膜基础的医学影像学研究[D].广州:南方医科大学,2008.

[18]黄冬娥,林木南,罗芳芳,等.基于“燔针取痹”探讨内热针治疗寒湿痹阻型腰椎间盘突出症对腰椎功能及疼痛症状改善效果[J].针灸临床杂志,2024,40(2):46-51.

[19]饶毅,吴群,蔡毅,等.内热针联合富血小板血浆对膝骨性关节炎患者外周血中T细胞亚群的影响[J].时珍国医国药,2025,36(1):104-108.

[20]曾思远.内热针治疗慢性腰痛(肾阳虚证)的疗效观察[D].长沙:湖南中医药大学,2020.

[21]郝晓东,唐宜春,方圆,等.中药蜡泥灸对气郁质、阳虚质失眠伴抑郁患者皮质醇、5-HT和证候红外热分布值的影响[J].基层中医药,2023,2(12):52-58.

[22]段轶轩,张照庆,尹晶,等.基于脊髓中枢敏化内热针干预慢性软组织疼痛机制研究[J].中国疼痛医学杂志,2021,27(12):888-897.

[23]薛梅梅.穴位热刺激对幻肢痛模型大鼠神经病理性痛的影响及机制研究[D].延安:延安大学,2022.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2026.05.012

中图分类号:R246.9

引用信息:

[1]李浩炜,陈梓瑜,常有刚,等.内热针治疗纤维肌痛综合征的临床研究[J].山东中医杂志,2026,45(05):520-526.DOI:10.16295/j.cnki.0257-358x.2026.05.012.

基金信息:

兰州市卫生健康行业医药卫生科研项目(编号:A2024024)

投稿时间:

2025-07-06

投稿日期(年):

2025

修回时间:

2025-10-14

终审时间:

2025-10-08

终审日期(年):

2025

审稿周期(年):

1

发布时间:

2026-05-05

出版时间:

2026-05-05

检 索 高级检索